News

April 7, 2022

Shengfang Jin, co-founder, President and CSO of ENSEM Therapeutics, has been featured in the ENSEM launch announcement through Endpoints News, an independent news organization that reports and analyzes the top global biotech and pharmaceutical R&D news of the day. Read More



April 6, 2022

ENSEM Therapeutics is proud to announce our Series A funding of $67 million to further advance our Kinetic EnsembleTM platform and accelerate R&D pipeline. Read More